About 180 Therapeutics

About company

180 Therapeutics is a therapeutics company that is focused on the development of novel biologic therapies for the treatment of fibrosis. It develops anti-TNF therapeutics. It mainly focuses on fibrosis in the liver, lung, and musculoskeletal system. 180 Therapeutics is focused on the research and evaluation of human disease tissues to understand how scarring and fibrosis occurs to produce diseases. 180 Therapeutics was founded by Glenn Larsen and is headquartered in Cambridge, Massachusetts.